Business Segments (Tables)

12 Months Ended

Jun. 30, 2014

Segment Reporting [Abstract]

Operating results and other financial information by segment

Operating results and certain other financial information about the Company’s three reportable segments for the years ended June 30, 2014, 2013 and 2012 and as of June 30, 2014 and June 30, 2013 were as follows (in thousands):

	For the year ended June 30, 2014
	Medical		CS		DSS		Corporate and Other Unallocated			Eliminations			Total
Sales (a)	$	162,648	$	83,119	$	109,134	$	—		$	(18,762	)	$	336,139
Gross profit	25,190		9,230		30,033		—			—			64,453
Operating income (loss)	12,561		4,106		19,943		(16,721		)	—			19,889
Selling and administrative expenses	10,499		3,950		8,750		12,499			—			35,698
Internal research and development expenses	—		—		1,169		—			—			1,169
Restructuring charges	—		188		—		—			—			188
Depreciation/amortization	4,820		1,756		1,149		398			—			8,123
Capital expenditures	872		540		1,090		999			—			3,501

	For the year ended June 30, 2013
	Medical		CS		DSS		Corporate and Other Unallocated			Eliminations			Total
Sales (a)	$	146,873	$	60,649	$	75,430	$	—		$	(18,325	)	$	264,627
Gross profit	21,287		6,388		17,760		—			—			45,435
Operating income (loss)	11,602		3,553		11,525		(10,639		)	—			16,041
Selling and administrative expenses	8,114		2,776		4,935		10,626			—			26,451
Internal research and development expenses	—		—		1,300		—			—			1,300
Restructuring charges	—		55		—		—			—			55
Depreciation/amortization	3,258		645		626		232			—			4,761
Capital expenditures	1,369		1,197		996		310			—			3,872

	For the year ended June 30, 2012
	Medical			CS		DSS		Corporate and Other Unallocated			Eliminations			Total
Sales (a)	$	110,894		$	53,609	$	76,980	$	—		$	(15,028	)	$	226,455
Gross profit	15,242			5,762		18,028		—			—			39,032
Operating income (loss)	8,685			2,985		12,945		(9,540		)	—			15,075
Selling and administrative expenses	6,152			2,777		3,790		9,513			—			22,232
Internal research and development expenses	—			—		1,293		—			—			1,293
Restructuring charges	(30		)	—		—		(38		)	—			(68		)
Depreciation/amortization	704			565		461		84			—			1,814
Capital expenditures	288			947		1,318		1,691			—			4,244

	As of June 30, 2014
	Medical		CS		DSS		Corporate and Other Unallocated		Eliminations		Total
Total assets	$	91,348	$	53,643	$	35,033	$	18,956	$	—	$	198,980

	As of June 30, 2013
	Medical		CS		DSS		Corporate and Other Unallocated		Eliminations		Total
Total assets	$	95,776	$	36,039	$	16,952	$	17,155	$	—	$	165,922

(a) Intercompany sales primarily represent CS production of circuit boards that are then utilized in DSS product sales. These intercompany sales are eliminated in consolidation.